跳至主要内容
临床试验/NCT07372911
NCT07372911招募中不适用

Corneal Wavefront Guided PRK Combined With Epi-off Corneal Cross-Linking Versus Epi-off Corneal Cross-Linking With PTK Epithelial Removal in Keratoconus: A Randomized Clinical Trial

Instituto de Oftalmología Fundación Conde de Valenciana1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Change in best-corrected distance visual acuity (logMAR)

研究概览

简要总结

Keratoconus causes irregular astigmatism and reduced vision. Epi-off corneal crosslinking (CXL) stabilizes the cornea but often leaves higher-order aberrations uncorrected. This randomized, parallel-group trial compares corneal wavefront guided photorefractive keratectomy (corneal wavefront guided PRK, 50 µm therapeutic ablation) combined with accelerated epi-off CXL versus epi-off CXL with epithelial removal by phototherapeutic keratectomy (PTK) using a Schwind AMARIS excimer laser, in adults with keratoconus. The primary endpoint is change in best-corrected distance visual acuity (logMAR) at 12 months. Key secondary endpoints include Kmax, corneal higher-order aberrations, manifest refraction, Scheimpflug densitometry (haze) and Fantes grade, Corvis ST biomechanics, NEI VFQ-25, and endothelial cell density by non-contact specular microscopy at 1, 3, 6 and 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-40 years
  • Diagnosis of keratoconus, ABCD Belin stage I-III at baseline
  • Minimum (thinnest) corneal pachymetry ≥ 450 µm pre-op
  • Written informed consent
  • Age-stratified progression requirements:
  • 18-25 y: keratoconus stage I-III (progression not mandatory)
  • 25-35 y: documented progression (meet ≥ 2 Table-1 criteria below) or, if recent documentation is absent, high-risk features for future progression: Kmax > 53 D, strong family history, severe atopy with persistent eye rubbing, or any of the following over 12 months: ΔKmax ≥ 1.0 D, thinnest pachymetry decrease ≥ 10 µm, or increase in manifest cylinder ≥ 1.0 D
  • 35-40 y: clear, unequivocal recent progression (meet ≥ 2 Table-1 criteria); late-onset documented progression may be considered

排除标准

  • Central corneal scars or opacities
  • Prior ocular surgery or trauma (exception: prior LASIK if it is the cause of post-surgical ectasia, per protocol text)
  • Autoimmune disease or uncontrolled diabetes mellitus
  • Pregnancy or lactation
  • Contact lens wear within 2 weeks before baseline evaluation

研究组 & 干预措施

Corneal Wavefront Guided PRK + CXL

Experimental

Corneal wavefront guided therapeutic PRK (50 µm) with Schwind AMARIS, followed by accelerated epi-off CXL. Intensity: 30 mW/cm² (pulsed 1 s on / 1 s off; 50% duty cycle). Total energy (fluence): 5.4 J/cm². Total time (elapsed): 6 minutes [equivalent to 3 minutes "on" time].

干预措施: Schwind AMARIS excimer laser (Device)

Corneal Wavefront Guided PRK + CXL

Experimental

Corneal wavefront guided therapeutic PRK (50 µm) with Schwind AMARIS, followed by accelerated epi-off CXL. Intensity: 30 mW/cm² (pulsed 1 s on / 1 s off; 50% duty cycle). Total energy (fluence): 5.4 J/cm². Total time (elapsed): 6 minutes [equivalent to 3 minutes "on" time].

干预措施: Corneal collagen crosslinking epi-off accelerated (Procedure)

PTK + CXL

Active Comparator

Epithelial removal by PTK using Schwind AMARIS, followed by accelerated epi-off CXL. Intensity: 30 mW/cm² (pulsed 1 s on / 1 s off; 50% duty cycle). Total energy (fluence): 5.4 J/cm². Total time (elapsed): 6 minutes [equivalent to 3 minutes "on" time].

干预措施: Schwind AMARIS excimer laser (Device)

PTK + CXL

Active Comparator

Epithelial removal by PTK using Schwind AMARIS, followed by accelerated epi-off CXL. Intensity: 30 mW/cm² (pulsed 1 s on / 1 s off; 50% duty cycle). Total energy (fluence): 5.4 J/cm². Total time (elapsed): 6 minutes [equivalent to 3 minutes "on" time].

干预措施: Corneal collagen crosslinking epi-off accelerated (Procedure)

结局指标

主要结局

Change in best-corrected distance visual acuity (logMAR)

时间窗: Baseline to 12 months

ETDRS-based CDVA in logMAR; change from baseline at 12 months; primary analysis by ANCOVA adjusted for baseline; one study eye per participant.

次要结局

  • Change in Kmax (Diopters)(Baseline; 3; 6; 12 months)
  • Change in corneal higher-order aberrations (µm RMS)(Baseline; 3,6,12 months)
  • Change in manifest refraction spherical equivalent (Diopters)(Baseline; 3;6;12 months)
  • Corneal haze (Scheimpflug densitometry units)(Baseline; 3;6;12 months)
  • Corvis ST metric: Ambrosio Relational Thickness horizontal (ART-h)(Baseline; 3,6; 12 months)
  • Visual Functioning Questionnaire (NEI VFQ-25)(Baseline; 6;12 months)
  • Endothelial cell density (cells/mm²; specular microscopy)(Baseline; 1; 3; 6; 12 months)
  • Serious corneal adverse events(Baseline to 12 months)
  • Corneal haze (Fantes grade)(Baseline; 3; 6; 12 months)
  • Corvis ST metric: Inverse Concavity Radius(Baseline; 3; 6; 12 months)

研究者

发起方
Instituto de Oftalmología Fundación Conde de Valenciana
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验